Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Mark Berner Hansen

(Tidligere)

Vis graf over relationer

Expertise

Extensive surgical and medical clinical expertise for gastrointestinal, pancreatic and hepatic diseases.

Extensive academic basic, translational and clinical research expertise with focus on neuro-endocrine physiology, pathology and pharmacology. 

Extensive experience and expertise for research and drug development (R&D) following more than 10 years employement in pharmaceutical companies (AstraZeneca and now Zealand Pharma) 

Primære forskningsområder

Gastrointestinal mucosa function in colorectal neoplasia; Gastrointestinal mucosa function in inflammatory bowel disease; Acute pancreatitis; Non-Alchoholic Steato-Hepatitis (NASH); Small Bowel Syndrome (SBS).

Aktuel forskning

Novel pharmacological targets for prevention and treatment of colorectal neoplasia/cancer

Novel pharmacological targets for the treatment of inflammatory bowel disease

Novel pharmacological tragerts for the treatment of NASH and SBS

Mulige interessekonflikter

VP Gastroenterology R&D employee at Zealand Pharma, a Copenhagen-based biotech company, developing medicines for endocrine, gastrointestinal and pancreatic indications.  

ID: 32367508